Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Yin_Weidong
|
| gptkbp:country |
gptkb:China
|
| gptkbp:founded |
1999
|
| gptkbp:founder |
gptkb:Yin_Weidong
|
| gptkbp:headquarters |
gptkb:Beijing,_China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sinovac
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:notableFor |
COVID-19 vaccine development
|
| gptkbp:product |
gptkb:CoronaVac
gptkb:Healive gptkb:Panflu gptkb:Panflu.1 Anflu |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:servesArea |
worldwide
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:SVA
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
http://www.sinovac.com
|
| gptkbp:bfsParent |
gptkb:COVID-19
|
| gptkbp:bfsLayer |
4
|